pentobarbital will lessen the level or influence of atogepant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Intently. Advised atogepant dosage with concomitant usage of powerful or average CYP3A4 inducers is thirty mg or 60 mg qDay. pentobarbital will lower the